Boc-L-His(Bzl)-OH

Boc-L-His(Bzl)-OH is a Boc-protected L-histidine derivative bearing a benzyl-protected side-chain on the imidazole nitrogen (His(Bzl)) for controlled reactivity during peptide assembly. This protected amino acid building block combines an acid-labile N-terminal protecting group with a side-chain-protected imidazole, enabling selective coupling while minimizing undesired side reactions from the histidine functional groups. Researchers use it as a histidine-containing residue precursor for constructing peptides where the protected imidazole must be preserved until later deprotection steps.

1. Solid-Phase Peptide Synthesis

Boc-L-His(Bzl)-OH is commonly used in peptide synthesis workflows that require a histidine residue with the imidazole side chain protected to maintain coupling selectivity and reduce side reactions. Peptide chemists incorporate this building block into custom sequences where histidine's imidazole can otherwise participate in undesired interactions during chain elongation. The Boc protection at the α-amino position supports iterative assembly strategies in which the N-terminus is deprotected and re-coupled under conditions compatible with the benzyl-protected side chain, making it a practical choice for preparing histidine-rich peptides and segments that later undergo global deprotection.

2. Histidine-Containing Segment Building

Boc-L-His(Bzl)-OH is frequently selected for preparing protected histidine-containing peptide segments used in longer fragment condensations and modular peptide assembly. In these workflows, the benzyl-protected imidazole helps keep the side chain inert during segment coupling and purification, supporting cleaner downstream handling before final deprotection. Medicinal chemistry groups and peptide manufacturing teams use this type of protected residue to reliably position histidine in defined sequence contexts, including peptides where the imidazole may be sensitive to activation conditions or where side-chain integrity is required through multiple synthetic steps.

3. Pharmaceutical Intermediate Peptide Synthesis

Boc-L-His(Bzl)-OH is used as a research-grade pharmaceutical intermediate building block for manufacturing and development of peptide-based candidates and advanced intermediates that contain histidine residues. Process development and custom synthesis teams favor protected amino acid derivatives like this one to improve synthetic robustness across multistep routes, especially when the imidazole must remain masked until a controlled deprotection stage. The Boc/benzyl protection pattern supports preparation of defined, sequence-accurate intermediates suitable for later conversion into deprotected peptides used in lead optimization and structure-activity relationship studies.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells